Precision Medicine News and Research

RSS

Research shows IQGAP1 as a common target in variants of triple negative breast cancer

The cover for issue 26 of Oncotarget features Figure 6, "Mislocalization of IQGAP1-BRCA1 in human TNBC tumors phenocopies the dominant mutants and the TNBC cells," by Osman, et al. and reported that IQGAP1 is a signaling scaffold implicated in TNBC, but its mechanism is unknown.

30 Jun 2020

WFIRM and Oracle Health Sciences team up to pair Body-on-a-Chip with data analytics

The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.

26 Jun 2020

Structured 'cut-and-paste' design enables streamlined development of SARS-CoV-2 molecular probes

A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.

24 Jun 2020

Organoids can help provide new level of accuracy in prescribing anti-cancer therapies

Precision medicine, using the power of the human genome to diagnose and treat patients, is about to get even more precise.

22 Jun 2020

Patient genetics associated with wound microbiome composition and healing

In a first-of-its-kind study, researchers have determined that genetics may play a role in how wounds heal.

22 Jun 2020

Ashion Analytics is now part of NCI's MATCH cancer clinical trials

Ashion Analytics, a clinical laboratory of the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is now part of the National Cancer Institute's MATCH program, which provides patients who have rare or difficult-to-treat cancers with access to unique clinical trials nationwide that might give them the best therapeutic treatments and outcomes.

12 Jun 2020

Using nanotheranostics approach to treat cancer

The concept of theranostics revolves around the stratification of patients into specific groups based on their response to different treatments and their disease risks.

10 Jun 2020

Gene expression may be a decisive factor for controlling possible comorbidities

A study led by the Barcelona Supercomputing Center, in which the Universitat de València participates, concludes that the specific characteristics of each patient, such as gene expression, may be a decisive factor in the development of clinical strategies aimed at addressing and controlling possible comorbidities.

8 Jun 2020

Current advances in nanoparticles and their role as anticancer drug-delivery vectors

Nanotechnology has contributed a great deal to the field of medical science. It has enabled researchers to design tools to deliver drugs to specific targets in a living organism.

4 Jun 2020

Computational models predict known biomarkers of inherited metabolic diseases

We are all unique. Our health is determined by our inherent genetic differences combined with our lifestyles and the environments in which we live.

4 Jun 2020

New guidelines on storage of genomic information, improvements in EHR systems

Advances in genetic and genomic testing technology have not only introduced the utilization of clinical genomic information into virtually every area of medical care, this testing has become an essential tool to achieve the goal of precision medicine.

2 Jun 2020

Chimeron Bio and George Mason NCBID partner to develop a coronavirus vaccine

Chimeron Bio, an RNA therapeutics company, and George Mason University's National Center for Biodefense and Infectious Diseases, a leading institute conducting pioneering research on infectious diseases.

30 May 2020

A Senator from Arizona emerges as a pharma favorite

Sen. Kyrsten Sinema formed a congressional caucus to raise "awareness of the benefits of personalized medicine" in February. Soon after that, employees of pharmaceutical companies donated $35,000 to her campaign committee.

29 May 2020

Pitt researcher to explore the neurological sex-based divide in dementia

Fifty million people worldwide are living with dementia, a broad term for diseases and conditions characterized by progressive cognitive decline.

28 May 2020

Methods to move precision medicine from evaluation into practice and policy

Value in Health, the official journal of ISPOR-;the professional society for health economics and outcomes research, announced today the publication of a series of articles focused on methods for moving from the evaluation of precision medicine into practice and policy.

26 May 2020

Precision Medicine News and Research

Research shows IQGAP1 as a common target in variants of triple negative breast cancer

WFIRM and Oracle Health Sciences team up to pair Body-on-a-Chip with data analytics

Structured 'cut-and-paste' design enables streamlined development of SARS-CoV-2 molecular probes

Organoids can help provide new level of accuracy in prescribing anti-cancer therapies

Patient genetics associated with wound microbiome composition and healing

Ashion Analytics is now part of NCI's MATCH cancer clinical trials

Using nanotheranostics approach to treat cancer

Gene expression may be a decisive factor for controlling possible comorbidities

Current advances in nanoparticles and their role as anticancer drug-delivery vectors

Computational models predict known biomarkers of inherited metabolic diseases

New guidelines on storage of genomic information, improvements in EHR systems

Chimeron Bio and George Mason NCBID partner to develop a coronavirus vaccine

A Senator from Arizona emerges as a pharma favorite

Pitt researcher to explore the neurological sex-based divide in dementia

Methods to move precision medicine from evaluation into practice and policy

Blood test could help doctors identify patients at risk of developing type 2 diabetes

Improving IVF Treatments by Imaging Sperm Cells

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

Precision medicine can determine the best drug treatment for severe heart disease

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News